Garlic Supplement Cholesterol Claims Halt Sought By CSPI
This article was originally published in The Tan Sheet
Executive Summary
Advertising claims that garlic supplements lower cholesterol, although literally true, are misleading "since the unsupported implication...is that taking garlic supplements is an effective means of reducing cholesterol levels," the Center for Science in the Public Interest advises FTC in a Dec. 5 petition.
You may also be interested in...
CSPI garlic petition denied
Center for Science in the Public Interest's citizen petition calling for a halt to "misleading" ad claims linking garlic supplements to lower cholesterol levels denied by FDA in recent letter. Citizen petitions are "not the appropriate vehicle to seek enforcement action," agency contends. However, FDA notes it will "review the information contained in your petition about particular products and claims" and consider whether a violation of the FD&C Act has occurred. CSPI submitted the petition to FDA almost two years ago (1"The Tan Sheet" Dec. 11, 2000, p. 8)...
CSPI garlic petition denied
Center for Science in the Public Interest's citizen petition calling for a halt to "misleading" ad claims linking garlic supplements to lower cholesterol levels denied by FDA in recent letter. Citizen petitions are "not the appropriate vehicle to seek enforcement action," agency contends. However, FDA notes it will "review the information contained in your petition about particular products and claims" and consider whether a violation of the FD&C Act has occurred. CSPI submitted the petition to FDA almost two years ago (1"The Tan Sheet" Dec. 11, 2000, p. 8)...
CSPI garlic petition denied
Center for Science in the Public Interest's citizen petition calling for a halt to "misleading" ad claims linking garlic supplements to lower cholesterol levels denied by FDA in recent letter. Citizen petitions are "not the appropriate vehicle to seek enforcement action," agency contends. However, FDA notes it will "review the information contained in your petition about particular products and claims" and consider whether a violation of the FD&C Act has occurred. CSPI submitted the petition to FDA almost two years ago (1"The Tan Sheet" Dec. 11, 2000, p. 8)...